Critically ill infants benefit from early administration of protein and energy-enriched formula: a randomized

Dick A van Waardenburg1, Carlijn T de Betue, Johannes B van Goudoever

  • 1Department of Pediatrics, Maastricht University and Medical Center, P Debeyelaan 25, Maastricht, The Netherlands. d.vanwaardenburg@mumc.n

Insights

A protein and energy-enriched infant formula improved nutrient intake and nitrogen balance in critically ill infants with respiratory failure. This enhanced nutritional support was well-tolerated and beneficial for recovery.

Area of Science:

  • Pediatric critical care nutrition
  • Infant respiratory failure management
  • Metabolic balance studies in infants

Background:

  • Nutritional support is crucial for critically ill infants but often hindered by feeding challenges.
  • Protein and energy-enriched formulas may overcome these barriers, promoting anabolism.
  • Respiratory syncytial virus (RSV)-bronchiolitis is a common cause of respiratory failure in infants.

Purpose of the Study:

  • To evaluate the efficacy of a protein and energy-enriched formula compared to a standard formula in critically ill infants.
  • To assess nutrient delivery, energy and nitrogen balance, and plasma amino acid concentrations.
  • To determine the tolerance and safety of the enriched formula.

Main Methods:

  • Randomized controlled trial involving infants with respiratory failure due to RSV-bronchiolitis.
  • Comparison of a protein and energy-enriched formula (PE-formula) versus a standard formula (S-formula).
  • Study duration of 5 days post-admission, monitoring nutrient intake, balance, and amino acid levels.

Main Results:

  • Infants receiving the PE-formula achieved higher nutrient intakes, meeting population reference intake (PRI) earlier than those on S-formula.
  • Significantly greater cumulative nitrogen balance (cNB) and energy balance (cEB) were observed in the PE-formula group (P<0.01).
  • Essential amino acid levels were higher in PE-fed infants, remaining within reference limits, unlike in S-fed infants.

Conclusions:

  • Early use of protein and energy-enriched formula in critically ill infants is well-tolerated.
  • Enriched formula promotes adequate nutrient intake and improves energy and nitrogen balance.
  • No adverse effects were observed, suggesting a safe and effective nutritional strategy.
Abstract

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...